Position in WGS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$411,900
New position
Shares Held
6,000
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#136
of 223 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $25,411,089 across 7 Diagnostics & Research names. WGS ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
26,520 | $9,946,060 | |
| 2 | DGX |
Quest Diagnostics Inc
|
24,000 | $5,086,800 | |
| 3 | LH |
Labcorp Holdings Inc.
|
12,400 | $3,472,000 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
6,909 | $3,463,896 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
105,542 | $2,165,721 | |
| 6 | RVTY |
Revvity, Inc.
|
7,772 | $864,712 | |
| 7 | WGS |
GeneDx Holdings Corp.
This page
|
6,000 | $411,900 |
All Filings in WGS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,900 | 6,000 | Shares | Other | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||